SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038889
Filing Date
2019-08-09
Accepted
2019-08-09 16:21:13
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv527108_10q.htm 10-Q 767818
2 EXHIBIT 31.1 tv527108_ex31-1.htm EX-31.1 8883
3 EXHIBIT 32.1 tv527108_ex32-1.htm EX-32.1 3996
  Complete submission text file 0001144204-19-038889.txt   8660092

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20190630.xml EX-101.INS 2827757
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20190630.xsd EX-101.SCH 59896
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20190630_cal.xml EX-101.CAL 54071
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20190630_def.xml EX-101.DEF 236195
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20190630_lab.xml EX-101.LAB 398709
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20190630_pre.xml EX-101.PRE 380881
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 191013234
SIC: 2834 Pharmaceutical Preparations